Skip to main content

Rocket One Inc.

RKTO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001711786

No open-market purchases or sales by Rocket One Inc. insiders were filed in the last 90 days; 21 institutions reported holding it in 13F filings for Q2 2026, worth $1.62M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Rocket One Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Rocket One Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Rocket One Inc.
NameTitleLast reported holdingLast filingFilings, past year
Knie RobbCEO and President547,387May 28, 20261
Sarnoff DavidDirector–May 28, 20261
Linsley WayneDirector–May 28, 20261
Pavell JeffDirector5,075May 28, 20261
Camarra Christopher MichaelDirector–May 28, 20261
Springer GraigDirector–Jan 15, 20250
Johns StefanieChief Scientific Officer–Mar 18, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 19, 2024 (view filing)Aug 163 daysKnie RobbCEO and PresidentPPurchase+25.0K$0.67+$16.8K+75.5%58.1K after
Sep 20, 2022 (view filing)8:00 AM ETSep 191 dayKnie RobbCEO and PresidentPPurchase+10.0K$0.39+$3.90K+1.2%828.3K after
Sep 19, 2022 (view filing)11:05 AM ETSep 163 daysKnie RobbCEO and PresidentPPurchase+10.0K$0.40+$4.00K+1.2%818.3K after